Current
3.5×
5-Year Average
6.2×
All-Time High
9.9×
All-Time Low
1.0×
P/S Ratio daily chart for Boston Scientific (BSX)
Jun 8, 2021 – Jun 5, 2026 · 1,255 trading days
Historical P/S Ratio for Boston Scientific (BSX) from 2001 to 2025
| 2025 | $141.38B | $20.07B | 7.0× | -0.8× | |
| 2024 | $131.68B | $16.75B | 7.9× | +1.9× | |
| 2023 | $84.71B | $14.24B | 5.9× | +0.7× | |
| 2022 | $66.29B | $12.68B | 5.2× | +0.1× | |
| 2021 | $60.54B | $11.89B | 5.1× | -0.1× | |
| 2020 | $51.33B | $9.91B | 5.2× | -0.7× | |
| 2019 | $63.05B | $10.74B | 5.9× | +0.9× | |
| 2018 | $48.92B | $9.82B | 5.0× | +1.2× | |
| 2017 | $34.04B | $9.05B | 3.8× | +0.3× | |
| 2016 | $29.46B | $8.39B | 3.5× | +0.3× | |
| 2015 | $23.87B | $7.48B | 3.2× | +0.8× | |
| 2014 | $17.58B | $7.38B | 2.4× | +0.1× | |
| 2013 | $15.98B | $7.14B | 2.2× | +1.2× | |
| 2012 | $7.83B | $7.25B | 1.1× | +0.1× | |
| 2011 | $7.72B | $7.62B | 1.0× | -0.5× | |
| 2010 | $11.56B | $7.81B | 1.5× | -0.2× | |
| 2009 | $13.60B | $8.19B | 1.7× | +0.2× | |
| 2008 | $11.62B | $8.05B | 1.4× | -0.6× | |
| 2007 | $17.38B | $8.36B | 2.1× | -1.2× | |
| 2006 | $25.26B | $7.82B | 3.2× | -0.0× | |
| 2005 | $20.33B | $6.28B | 3.2× | -2.0× | |
| 2004 | $29.60B | $5.62B | 5.3× | -3.7× | |
| 2003 | $31.01B | $3.48B | 8.9× | +3.0× | |
| 2002 | $17.19B | $2.92B | 5.9× | +2.2× | |
| 2001 | $9.89B | $2.67B | 3.7× | — |
- 20257.0×
- 20247.9×
- 20235.9×
- 20225.2×
- 20215.1×
- 20205.2×
- 20195.9×
- 20185.0×
- 20173.8×
- 20163.5×
- 20153.2×
- 20142.4×
- 20132.2×
- 20121.1×
- 20111.0×
- 20101.5×
- 20091.7×
- 20081.4×
- 20072.1×
- 20063.2×
- 20053.2×
- 20045.3×
- 20038.9×
- 20025.9×
- 20013.7×
About P/S Ratio at Boston Scientific (BSX)
Boston Scientific (BSX) P/S ratio is 3.5× as of June 5, 2026. The 5-year average is 6.2×. The sector median currently stands at 3.5×. The current ratio is at the 0th percentile of its own 10-year history.
Boston Scientific (BSX) historical P/S ratio has ranged from a low of 1.0× (2011) to a high of 9.9× (2025) in the available daily series.
The price-to-sales (P/S) ratio compares a company's market capitalisation to its trailing twelve-month (TTM) revenue. It is calculated as market cap ÷ TTM revenue (equivalent to share price ÷ TTM revenue per share). Because the denominator (revenue) cannot be negative, P/S is widely used to value unprofitable or pre-profit companies and to make cross-sector comparisons.
Boston Scientific P/S Ratio by Year
Boston Scientific P/S Ratio 2025: 7.0×
Boston Scientific (BSX) P/S ratio in 2025 was 7.0×, contracted from 7.9× the prior year.
Boston Scientific P/S Ratio 2024: 7.9×
Boston Scientific (BSX) P/S ratio in 2024 was 7.9×, expanded from 5.9× the prior year.
Boston Scientific P/S Ratio 2023: 5.9×
Boston Scientific (BSX) P/S ratio in 2023 was 5.9×, expanded from 5.2× the prior year.
Boston Scientific P/S Ratio 2022: 5.2×
Boston Scientific (BSX) P/S ratio in 2022 was 5.2×, expanded from 5.1× the prior year.
Boston Scientific P/S Ratio 2021: 5.1×
Boston Scientific (BSX) P/S ratio in 2021 was 5.1×.
Sector peers by P/S Ratio — chart
Current ratio vs. sector peers. Highlighted bar is this company.
Sector peers by P/S Ratio — table
Healthcare peers of Boston Scientific (BSX), ranked by P/S ratio.
| 2.1× | |
| 2.1× | |
| 2.1× | |
| 1.9× | |
| 1.9× | |
| 1.7× | |
| 1.6× | |
| 1.6× | |
| 1.4× | |
| 1.4× | |
| 1.1× | |
| 0.8× | |
| 0.7× | |
| 0.6× | |
| 0.6× | |
| 0.5× | |
| 0.3× | |
| 0.3× | |
| 0.3× | |
| 0.2× | |
| 0.2× | |
| 0.2× | |
| 0.2× | |
| 0.2× | |
| 0.1× |
- 2.1×
- 1.7×
- 1.4×
- 1.1×
- 0.7×
- 0.3×
- 0.3×
- 0.2×
- 0.2×
- 0.2×
- 0.1×
Frequently asked questions
Boston Scientific (BSX) Key Financials
Charts, filings, and peer comparison for every metric